Related Experiment Video
Updated: Aug 28, 2025

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
A child with dendritiform eye lesions and developmental delay.
Vasiliki Gliagias1, Ksenia Denisova2, Joann J Kang2
1Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Tyrosinemia Type II, a rare metabolic disorder, can cause eye and skin issues and developmental delays. Early diagnosis through ocular signs, even with negative newborn screening, is crucial for prompt treatment and preventing developmental delay.
Area of Science:
- Ophthalmology
- Genetics
- Metabolic Disorders
Background:
- Tyrosinemia Type II (Richner-Hanhart syndrome) is a rare autosomal recessive disorder caused by tyrosine aminotransferase deficiency.
- It can lead to severe oculocutaneous manifestations, including ulcerated keratitis.
Observation:
- A 15-month-old boy with a negative newborn screen presented with unilateral epithelial defects and palmoplantar hyperkeratosis.
- He later developed bilateral dendritiform epithelial erosions and global developmental delay.
- Diagnosis of Tyrosinemia Type II was confirmed by elevated tyrosine and phenylalanine levels.
Findings:
- The patient's ocular symptoms and epithelial defects resolved after initiating a low-protein diet.
- This case highlights the potential for oculocutaneous tyrosinemia despite negative newborn screening.
Implications:
- Dendritiform epithelial erosions, developmental delay, and palmoplantar hyperkeratosis warrant tyrosine and phenylalanine level measurement.
- Early recognition of ocular signs is vital for timely diagnosis and intervention.
- Prompt dietary modification is essential to prevent irreversible developmental delay in Tyrosinemia Type II.
More Related Videos
09:00Eye Removal in Living Zebrafish Larvae to Examine Innervation-dependent Growth and Development of the Visual System
Published on: February 11, 2022
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023